Trabectedin and Radiation Therapy for Cardiac Metastasis From Leiomyosarcoma: A Case Report and Review of the Literature

Leiomyosarcoma (LMS) is one of the most frequent subtypes of soft-tissue sarcomas (STSs). Metastatic spread to the heart in cancer patients carries a poor prognosis and there is no known effective treatment. Cardiac metastases of STSs are very rare. Here we present the case of a 55-year-old patient...

Full description

Bibliographic Details
Published in:	Frontiers in Oncology
Main Authors:	Ilaria Tortorelli, Federico Navarria, Antonio Di Maggio, Alberto Banzato, Chiara Lestuzzi, Luca Nicosia, Benedetta Chiusole, Antonella Galiano, Marta Sbaraglia, Vittorina Zagonel, Antonella Brunello
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Subjects:	leiomyosarcoma radiotherapy trabectedin chemotherapy cardiac metastasis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.838114/full

Similar Items

Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma
by: W. Lamm, et al.
Published: (2010-12-01)

Doxorubicin and trabectedin for recurrent leiomyosarcoma – A case report
by: Gabriel Levin, et al.
Published: (2024-10-01)

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
by: María Jesús Rubio, et al.
Published: (2020-08-01)

Long-Time Progression-Free Survival with Trabectedin in Chemorefractory Metastatic Leiomyosarcoma of the Retroperitoneum: A Case Report
by: Andreas Reichinger
Published: (2023-09-01)

Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of18FDG-PET-CT in Assessing Treatment Response
by: M.J. Payne, et al.
Published: (2014-02-01)

Neoadjuvant Trabectedin plus Radiotherapy in High-Grade Sarcoma of the Leg: A Case Report
by: António José Loureiro da Silva, et al.
Published: (2018-07-01)

Long-Term Progression-Free Survival in a Patient with Metastatic Leiomyosarcoma of the Inguinal Region Treated with Trabectedin
by: Ferdinand Haslbauer
Published: (2018-04-01)

Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study
by: Sercan Ön, et al.
Published: (2024-11-01)

Long lasting response of trabectedin in patient with gastric leiomyosarcoma with liver metastasis: an update to previous report
by: Sameer Rastogi, et al.
Published: (2020-01-01)

Long-Term Response after 94 Cycles of Trabectedin in a Patient with Metastatic Leiomyosarcoma of the Lower Extremity
by: Magda Cordeiro, et al.
Published: (2020-02-01)

Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report
by: Irene Carrasco García, et al.
Published: (2024-01-01)

Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedin
by: Pawel Sobczuk, et al.
Published: (2025-02-01)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
by: Audrey Laroche, et al.
Published: (2017-04-01)

Efficacy of trabectedin in metastatic solitary fibrous tumor
by: Xavier Pivot, et al.
Published: (2011-07-01)

A Clear Cell Sarcoma Case: A Diagnostic and Treatment Challenge, with a Promising Response to Trabectedin
by: Mar Galera, et al.
Published: (2023-12-01)

Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
by: Eva María Guerra Alía, et al.
Published: (2019-06-01)

The value of trabectedin in the treatment of soft tissue sarcoma
by: Nakamura T, et al.
Published: (2016-01-01)

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
by: Desar IME, et al.
Published: (2016-08-01)

Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients
by: Giuseppe Corona, et al.
Published: (2023-08-01)

Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model
by: Omar Keritam, et al.
Published: (2022-06-01)

Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?
by: Boccia SM, et al.
Published: (2024-06-01)

Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity
by: Adrián Povo-Retana, et al.
Published: (2023-08-01)

Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights
by: David G. Gent, et al.
Published: (2022-11-01)

Real-life experience using trabectedin plus pegylated liposomal doxorubicin combination to treat patients with relapsed ovarian cancer
by: Saad Tahir
Published: (2014-12-01)

When DNA Repair Backfires – Trabectedin Induces DNA Breaks in Active Genes
by: Vakil Takhaveev, et al.
Published: (2025-04-01)

Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin
by: Annie J. Tsay, et al.
Published: (2024-10-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
by: Carlos M. Galmarini, et al.
Published: (2014-01-01)

A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin
by: David S. Moura, et al.
Published: (2021-12-01)

A rare case of leiomyosarcoma of the prostate: Treatment and review of literature
by: Gopal Pemmaraju, et al.
Published: (2021-01-01)

Severe Rhabdomyolysis during Treatment with Trabectedin in Combination with a Herbal Drug in a Patient with Metastatic Synovial Sarcoma: A Case Report
by: Angela Damato, et al.
Published: (2017-03-01)

Changes after sterile inflammation caused by trabectedin infusion from central venous port: A case report
by: Jun Kamohara, MD, et al.
Published: (2024-10-01)

Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
by: Maria Cucè, et al.
Published: (2019-03-01)

A decade of insight: Understanding primary Leiomyosarcoma of the bone
by: Himanshu Rohela, et al.
Published: (2025-04-01)

Leiomyosarcoma of the Prostate: Report of Two Cases and Review of the Literature
by: Ons Bettaieb, et al.
Published: (2024-03-01)

Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy
by: Adrián Povo-Retana, et al.
Published: (2024-01-01)

Surgical resection of liver metastasis of leiomyosarcoma
by: Yong Woon Kim, et al.
Published: (2017-12-01)

Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas
by: Stephen Poitureau, et al.
Published: (2025-08-01)

Analysis of demographics and treatment outcomes for gastrointestinal leiomyosarcoma based on the SEER database
by: Yanan Bao, et al.
Published: (2025-03-01)

Radiological evaluation of response in patients with locally advanced/metastatic soft tissue sarcoma treated with trabectedin
by: S. Ceddia, et al.
Published: (2024-08-01)

Trabectedin may be a valuable treatment option for elderly patients with metastatic soft tissue sarcomas
by: Gianmaria Miolo, et al.
Published: (2024-07-01)